Swiss ICT Investor Club (SICTIC)
Storys zum Thema Investures
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Good Results for the Cornèr Group
Lugano (ots) - Following a highly turbulent year, which saw the outbreak of the war in Ukraine and abrupt interest rate rises by the main central banks around the world, the Cornèr Group has now posted good results in its 71st Annual Report. Revenues increased to CHF 436 million, whilst the net profit rose to CHF 53.2 million, representing a strong increase compared to the previous year (CHF 22.7 million). ...
2 DokumentemehrInnovation Park Zurich / Development company IPZ Property Ltd's shareholder base receives boost / The Angst+Pfister Group is acquiring substantial share
Zurich (ots) - Following the successful completion of the political process, the Innovation Park Zurich is registering another import step in its development - the Angst+Pfister Group, which operates internationally, is coming on board as a major investor in the generation project. This process is now well under way ...
mehrExcellent development: Sedus Stoll AG on course for further growth
mehr- 2
Green completes a CHF 480 million refinancing and accelerates its investment programs in Switzerland
mehr Investment in VAYU® / You want to be a part of the VAYU® Family?
mehrDebiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Lausanne (ots) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm ...
mehrCredaris and Milenia join forces
mehrPositive operating result for SIFEM in 2021 - and new investment cooperation with SDC
Bern (ots) - In 2021, the Swiss Investment Fund for Emerging Markets (SIFEM) committed a total of USD 84 million to seven new investments and concluded the year with a positive operating result of CHF 40.3 million. Also, 2021 marked the beginning of a new type of cooperation between SIFEM and the Swiss Agency for Development and Cooperation (SDC). The two partners have ...
mehr- 2
Zurich startup REBELS 0.0% receives 1 million investment for EU expansion
mehr DEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
mehrVeriSIM Life Secures $15 Million Series A Funding
San Francisco, CA (ots) - Financing led by Morpheus Ventures supports further revenue growth for the company’s next-generation AI platform, redefining the preclinical translational drug development landscape by accurately predicting and accelerating clinical outcomes VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug ...
mehrelea Foundation for Ethics in Globalization
Peter Maurer is set to join elea Foundation's Comité de Patronage
mehrFirst SIFEM investment in Nepal - and first cooperation between SIFEM and SDC
Bern (ots) - The Swiss Investment Fund for Emerging Markets (SIFEM) made its first investment in Nepal, a focus country of Switzerland's development cooperation.SIFEM supports NMB Bank Limited with a loan of USD 12 million that will be used for lending to local businesses.This investment will give micro, small and medium enterprises (MSMEs) access to finance and will ...
mehrSwiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
mehrAnapaya Strengthens Board of Directors with International Industry Leaders
mehrChina Matters releases an animated video of Yantai: China's Window to East Asia
Beijing (ots) - Yantai, a famous coastal city in East China, is becoming an important window for the country to communicate with its East Asian neighbors. Adjacent to Japan and South Korea as a large port, Yantai is home to investors from these two countries. The Yantai China-South Korea Industrial Park, as a vital sign of the city's goal of attracting foreign ...
mehrAnapaya closes 6.8M CHF financing round with lead investor SIX Fintech Ventures
mehrBullfinch AG and Aquila Capital launch Joint Investment Vehicle for energy-efficient assets
mehrMTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
mehrGreen invests half a billion francs in the digital location Switzerland / Green is building its second data center campus, which will house three high-performance data centers and a business park
Switzerland - Zurich (ots) - With its IT infrastructure, Green helps to ensure that the economy is based on strong foundations and it serves as an important partner for international cloud providers. The company is now expanding its presence with a prominent statement: the Zurich Metro Campus - comprising three ...
mehrBelgian scale-up Oncomfort raises EUR10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop its Digital SedationTM through Virtual Reality
mehrThe Future of Real Estate: Sustainable Construction Innovation
Stuttgart (ots) - How are market leaders answering to the current sustainability challenges? Which sustainability goals did they set themselves? Which strategies have they put in place to achieve those goals? We will discuss these and other important questions in our free virtual Strybinar. Learn from successful industry leaders and innovators within the DACH market on ...
mehrtheScreener Investor Services AG
2New and radically different - theScreener CIO
mehrPositive operating result for SIFEM in 2019 - and uncertain outlook for 2020 due to the COVID-19 crisis
Bern (ots) - In 2019, the Swiss Investment Fund for Emerging Markets (SIFEM) committed a total of USD 104.5 million across nine different projects and concluded the year with a positive operating result of CHF 5.1 million. However, the outlook for SIFEM's portfolio in 2020 has taken a sudden negative turn in the ...
mehrThomasLloyd Global Asset Management GmbH
ThomasLloyd 2020 inaugural Indian Investment Symposium
New Dehli, India (ots) - ThomasLloyd is proud to have held its inaugural Indian Investment Symposium in New Delhi on 3rd/4th February 2020. The symposium focused on inward investment from Europe to support the current and future expansion of sustainable infrastructure and renewable energy in India. Attended by 120 European delegates and representatives of the High Commissions and Embassies of the United Kingdom, ...
mehrMSD Expands Operations in Switzerland
Lucerne (ots) - - Company will open a new location in Zurich, focused on accelerating research, data and commercialization of our medicines and vaccines - Lucerne will remain the center of MSD's presence in Switzerland MSD (Merck Sharp & Dohme AG) today announced that it will establish a new office in Zurich, Switzerland, aimed at accelerating the ...
Ein DokumentmehrTrade Policy Reviews of Peru at the WTO / The fifth review of the trade policies and practices of Peru takes place on 22 and 24 October 2019
mehrMicreos Raises EUR30 Million for Endolysin Technology Set to Replace Antibiotics / Funding for clinical development program XZ.700 and Gladskin Eczema USA launch
THE HAGUE, Netherlands (ots) - Dutch biotechnology company Micreos announced it has secured EUR30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and the USA launch of its ...
mehrPioneer and trendsetter: latest KfW Sustainability Report "Promoting perspectives - empowering people" now available
Frankfurt/Main (ots) - - Major contribution to realising the United Nations' Sustainable Development Goals. - 2017: EUR 33.2 billion for climate action and environmental protection projects - Ambitious sustainability programme for 2018 Today KfW published the first part of its Sustainability Report 2017 entitled ...
mehr